The observed weight loss might not be as high as with some of the newer injectable GLP-1 medications, he says, but the oral pills offer the potential of having an inexpensive, accessible drug. Both pills must be taken daily, whereas many GLP-1 injections are weekly
Compounded GLP-1 medications referenced in this article are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality before marketing
Concerns about discontinuing AOMs Obesity, affecting over 2.2 billion adults globally in 2020 and projected to rise to 3.3 billion by 2035, is linked to significant health risks, including some cancers, cardiovascular disease, and type 2 diabetes
The difference between those two scenarios is literally thousands of dollars and months of delayed access to transformative treatment
"The metabolic actions of glucagon revisited." Nature Reviews Endocrinology , 2010
They will be able to provide specific guidance tailored to the product being prescribed